According to Puri Pharmaceuticals, recently, Prima Pharmaceuticals received marketing licenses for voriconazole injections issued by the Spanish Medicines and Medical Devices Agency, the Dutch Drug Evaluation Commission, and the Portuguese National Drug and Health Products Administration, respectively, indicating that the drug is eligible for marketing and sale in Spain, the Netherlands, and Portugal.

According to Puri Pharmaceuticals, recently, Prima Pharmaceuticals received marketing licenses for voriconazole injections issued by the Spanish Medicines and Medical Devices Agency, the Dutch Drug Evaluation Commission, and the Portuguese National Drug and Health Products Administration, respectively, indicating that the drug is eligible for marketing and sale in Spain, the Netherlands, and Portugal.